Preferred Medicine is a precision oncology company that is focused on providing a simple blood test aimed at providing early cancer detection. By combining the power of miRNA and AI technologies, as we pursue detecting the world’s most common cancers at high accuracy.
The company’s goal is to widen access to cancer screening for all patients - helping to reduce emotional stress and healthcare costs, all while improving care, quality of life, and in many cases, saving lives.
We are excited to continue the current development of our first product PREMIR, for patients with high-risk for breast cancer. PREMIR offers physicians a quick and simple early detection screening test, combined with our proprietary technology.
Preferred Medicine is headquartered in Burlingame, CA, USA. It is supported by a leading global investor and AI technology company.
For more information, please visit www.preferred-medicine.com
Company Details
- Founded
- -
- Address
- Burlingame, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- cancer detection, oncology, clinical study, artificial intelligence, cancer biology, machine learning, molecular biology.
- HQ
- Burlingame, CA
Preferred Medicine, Inc. Questions
Preferred Medicine, Inc.'s website is http://www.preferred-medicine.com
Preferred Medicine, Inc.'s LinkedIn profile is https://www.linkedin.com/company/preferred-medicine
Preferred Medicine, Inc.'s industry is
Biotechnology Research
Preferred Medicine, Inc.'s top competitors are
Dispatchhealth,
ノーベルファーマ株式会社 Nobelpharma Co., Ltd,
Thinkie Inc,
Genesys,
Atransen Pharma Ltd,
Preferred Infrastructure,
Twitch,
Symic Bio,
Preferred Networks, Inc.,
Arima Genomics.
Preferred Medicine, Inc.'s categories are Biotechnology Research
Preferred Medicine, Inc.'s founding year is 2018
